ASX Release | 28 October 2026 Quarterly Activities Report : Expanded GBS opportunity, Asia - Pacific R&D platform established and diagnostics pipeline broadened Highlights: • Expansion of Group B Streptococcus (“GBS”) program and accelerated commercial opportunities Proposed 50:50 joint...